Global Colchicine Market Size, Share and Trends Analysis Report,By Type (Tablet, Oral Solution), By Application (Acute Gout, Chronic Gout, Other Conditions), Forecast (2022-2028)

The global Colchicine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Colchicine is a drug used to treat gout and is marketed under the brand names colcry, mitigare, zyclochin, and others. The FDA government has placed a ban on the drug Colchicine. Colchicine has been used as an anti-gout and anti-inflammatory medication for many years. Its purpose is to reduce the amount of uric acid in the blood. It is available in a variety of forms such as tablets, capsules, ointment, and so on. The primary function of colchicine is to prevent gout disease. This drug is also used to treat FMF (Family Mediterranean fever). This drug’s applications industries include chemical, pharmaceutical, and agricultural and so on.

The rising global burden of gout and rising global incidences of arthritis are the major driving factors boosting market growth. Looking towards the demand for colchicines, key players are adopting different market expansion activities. For instance, in September 2021, Pendopharm, a division of Pharmascience Inc., is pleased to announce the Canadian launch of MYINFLATM (colchicine 0.5 mg extended-release tablets), a previously prescribed medication that has been repurposed as a new treatment option for the reduction of cardiovascular risks in patients with preexisting coronary artery disease. All medical professionals can now access this treatment.

Market Coverage

  • The market number available for – 2021-2028
  • Base year- 2021
  • Forecast period- 2022-2028
  • Segment Covered-
    • By Type
    • By Application
  • Regions Covered-
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World
  • Competitive Landscape- ROMEG Therapeutics, Genpharma, Prasco Laboratories, Alkem Laboratories, Amneal Pharmaceuticals, Inc., Zydus Pharmaceuticals, Inc., among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How has COVID-19 impacted the market?
    • Deviation from the pre-COVID-19 forecast
    • Most affected region and segment
  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Colchicine Market Report by Segment

By Type

  • Tablet
  • Oral Solution

By Application

  • Acute Gout
  • Chronic Gout
  • Other Conditions

Global Colchicine Market Report by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific

Rest of the World

  • Latin America
  • Middle East & Africa

The report will be delivered within 48-72 hours after payment confirmation